Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones.


Journal

Experimental cell research
ISSN: 1090-2422
Titre abrégé: Exp Cell Res
Pays: United States
ID NLM: 0373226

Informations de publication

Date de publication:
15 06 2020
Historique:
received: 25 11 2019
revised: 28 02 2020
accepted: 01 03 2020
pubmed: 13 4 2020
medline: 1 1 2021
entrez: 13 4 2020
Statut: ppublish

Résumé

Melanoma is characterized by high heterogeneity and plasticity, most likely due to the presence of mutated melanocyte stem cells or immature progenitor cells in the skin that serves as precursors to melanoma. In the present study, for the first time, we identified rare cells in the murine melanoma B16F10, and human A2058 and SK-MEL-28 cell lines that express pluripotency markers, including Oct4, Nanog, Sox2 and a marker of melanoma cancer cells (ALDH1/2). These cells are very small with round morphology and they grow onto melanoma cells, thereby demonstrating feeder layer dependence similar to that of other pluripotent cells. These cells underwent self-renewal, symmetric and asymmetric division. We called these cells murine very small cancer stem cells (VSCSC). VSCSC were also found in B16F10-derived clones after 3-5 consecutive passages, where they occur as single cells or as small colonies, nevertheless, always using melanoma cells as feeders. These cells formed melanospheres enriched with Oct4-and ALDH1/2-positive cells. We also evaluated the possible effect of VSCSC that presented in the parental cell line (B16F10) and in clones based on their functional characteristics. We found that VCSCS present in the B16F10 cell line reappearing in their clones were required for continuous tumor growth and were responsible for melanoma cell heterogeneity and plasticity rather than directly affecting functional characteristics of melanoma cells. Our data, together with those of previous reports suggested the existence of melanoma-competent melanocyte stem cells, which corroborate the hypothesis of the existence of tumor-initiating cells and cancer stem cell hierarchies, at least in melanoma.

Identifiants

pubmed: 32278688
pii: S0014-4827(20)30143-9
doi: 10.1016/j.yexcr.2020.111938
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Octamer Transcription Factor-3 0
Pou5f1 protein, mouse 0
SOXB1 Transcription Factors 0
Sox2 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111938

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Diana Aparecida Dias Câmara (DA)

Laboratory of Genetics, Butantan Institute, Sao Paulo, SP, Brazil; Universidade Federal de Sao Paulo, Programa de Pós-graduação em Biologia Estrutural e Funcional, SP, Brazil. Electronic address: diana.adc@gmail.com.

Paulo Luiz de Sá Junior (P)

Universidade Mogi das Cruzes (UMC), Villa Lobos Campus, São Paulo, SP, Brazil. Electronic address: paulsaj2001@yahoo.com.br.

Ricardo Alexandre de Azevedo (R)

Experimental Oncology Unit (UNONEX), Microbiology, Immunology and Parasitology Department, Federal University of Sao Paulo, Sao Paulo, SP, Brazil.

Carlos Rogério Figueiredo (CR)

Experimental Oncology Unit (UNONEX), Microbiology, Immunology and Parasitology Department, Federal University of Sao Paulo, Sao Paulo, SP, Brazil; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.

Rodrigo Pinheiro Araldi (RP)

Laboratory of Genetic Basis of Thyroid Cancer, Federal University of Sao Paulo, Brazil.

Debora Levy (D)

Laboratory of Genetics and Molecular Hematology (LIM31), University of Sao Paulo School of Medicine, Sao Paulo, SP, Brazil.

Dener Madeiro de Souza (D)

Laboratory of Genetics, Butantan Institute, Sao Paulo, SP, Brazil.

Irina Kerkis (I)

Laboratory of Genetics, Butantan Institute, Sao Paulo, SP, Brazil. Electronic address: irina.kerkis@butantan.gov.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH